Adoptive cell therapy for lymphoma with CD4 T cells depleted of CD137-expressing regulatory T cells (Q35803631)

10 August 2017

Adoptive cell therapy for lymphoma with CD4 T cells depleted of CD137-expressing regulatory T cells (English)

1 reference

10 August 2017

Matthew J Goldstein

1

1 reference

10 August 2017

Holbrook E Kohrt

2

1 reference

10 August 2017

Roch Houot

3

1 reference

10 August 2017

Bindu Varghese

4

1 reference

10 August 2017

Jack T Lin

5

1 reference

10 August 2017

Erica Swanson

6

1 reference

10 August 2017

Ronald Levy

7

1 reference

10 August 2017

language of work or name

English

0 references

publication date

9 January 2012

1 reference

10 August 2017

1 reference

10 August 2017

72

1 reference

10 August 2017

5

1 reference

10 August 2017

1239-1247

1 reference

A CpG-loaded tumor cell vaccine induces antitumor CD4 T cells that are effective in adoptive therapy for large and established tumors

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

LAG-3 expression defines a subset of CD4( )CD25(high)Foxp3( ) regulatory T cells that are expanded at tumor sites

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Naive tumor-specific CD4( ) T cells differentiated in vivo eradicate established melanoma.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Tumor-reactive CD4( ) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Wnt signaling arrests effector T cell differentiation and generates CD8 memory stem cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Treatment of metastatic melanoma with autologous CD4 T cells against NY-ESO-1

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

The effector to memory transition of CD4 T cells.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Immunostimulatory monoclonal antibodies for cancer therapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Host-reactive CD8 memory stem cells in graft-versus-host disease

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

A peripheral circulating compartment of natural naive CD4 Tregs

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Naturally arising Foxp3-expressing CD25 CD4 regulatory T cells in immunological tolerance to self and non-self

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Transformation of bone marrow B-cell progenitors by E2a-Hlf requires coexpression of Bcl-2.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Melanoma-Reactive CD8 T cells recognize a novel tumor antigen expressed in a wide variety of tumor types

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

The central role of CD4( ) T cells in the antitumor immune response

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Two functional subsets of FOXP3 regulatory T cells in human thymus and periphery

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

Differential expression of CCR7 defines two distinct subsets of human memory CD4 CD25 Tregs

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

The generation of protective memory-like CD8 T cells during homeostatic proliferation requires CD4 T cells

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294169

MHC class II expression identifies functionally distinct human regulatory T cells

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22232735

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22232735

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/0008-5472.CAN-11-3375

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

22232735

1 reference